Verkazia Alternatives Compared
Verkazia (cyclosporine) | Maxitrol (dexamethasone / neomycin / polymyxin b) | Diclofenac ophthalmic |
|
---|
Verkazia (cyclosporine) | Maxitrol (dexamethasone / neomycin / polymyxin b) | Diclofenac ophthalmic |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Keratoconjunctivitis. Verkazia may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Blepharitis, Conjunctivitis - Bacterial, Uveitis, Keratitis, Keratoconjunctivitis. Maxitrol may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Corneal Ulcer, Conjunctivitis, Postoperative Ocular Inflammation, Inhibition of Intraoperative Miosis, Keratoconjunctivitis. Diclofenac ophthalmic may also be used for purposes not... View more |
Related suggestions |
|||||||||||||||||||||||
More about Verkazia (cyclosporine) | More about Maxitrol (dexamethasone / neomycin / polymyxin b) | More about Diclofenac ophthalmic | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Be the first to share your experience with this drug. |
Maxitrol has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Diclofenac ophthalmic has an average rating of 6.3 out of 10 from a total of 3 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Verkazia side effects |
View all Maxitrol side effects |
View all Diclofenac ophthalmic side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Verkazia prices |
View all Maxitrol prices |
View all Diclofenac ophthalmic prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other cyclosporine brands include: Cequa, Restasis, Vevye | Other dexamethasone / neomycin / polymyxin b brands include: AK-Trol, Dexacine, Dexasporin, Neo-Poly-Dex, NPD Ophthalmic Ointment, Poly-Dex | Voltaren Ophthalmic | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 15 drugs are known to interact with Verkazia:
|
A total of 98 drugs are known to interact with Maxitrol:
|
A total of 74 drugs are known to interact with Diclofenac ophthalmic:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
June 23, 2021 |
July 19, 1963 |
N/A |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.